NL-OMON36574
Completed
Not Applicable
Assessment of tumor hypoxia during radiotherapy course in locally advanced Head and Neck cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET-CT - FAZA pilot study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- hoofd hals kanker
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* Intended curative primary (chemo)radiation for patients with locally advanced HNSCC.
- •\* Age \* 18 years.
- •\* WHO performance status 0\-2 (see appendix 1\)
- •\* Histological of cytological confirmation of HNSCC
- •\* Locally advanced HNSCC (stage III\-IV), TNM classification \[8]
- •\* Staging procedure should at least include CT\-neck, MRI\-neck and 18F\-FDG\-PET\-scan
- •\* Life expectancy of at least 6 months
- •\* Planned for 35 x 2 Gy IMRT eventually with concomitant chemotherapy
- •\* Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow\-up schedule; those conditions should be discussed with the patient before registration in the trial.
- •\* Before patient registration/randomisation, written informed consent must be given according to ICH/EU GCP, and national/local regulations.
Exclusion Criteria
- •Not fullfilling the inclusioncriteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of tumor hypoxia for stereotactic radiotherapy using F-18 fluoromisonidazoleung cancerJPRN-UMIN000028332Kindai University15
Completed
Not Applicable
Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PETRadioembolizationRadiotherapyCancerPositron Emission TomographyNCT06027021Ankara University64
Withdrawn
Not Applicable
A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZAHypoxic TumoursNCT00756691AHS Cancer Control Alberta
Not yet recruiting
Not Applicable
The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer.advanced non-small cell lung cancerJPRN-UMIN000041659Saitama Medical University International Medical Center20
Not yet recruiting
Phase 2
Validation of hypoxia imaging of cancer in the head and neck area with FAZA-PETNL-OMON32369Antoni van Leeuwenhoek Ziekenhuis20